The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

OBJECTIVES: To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal women treated with ospemifene compared with placebo. METHODS: Analysis of two multicenter, randomized, double-blind, 12-week phase-III studies in postmenopausal women (40–80 years...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Climacteric
Egile Nagusiak: Nappi, R. E., Panay, N., Bruyniks, N., Castelo-Branco, C., De Villiers, T. J., Simon, J. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438339/
https://ncbi.nlm.nih.gov/pubmed/25335119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/13697137.2014.975199
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak